Earnings History Data for Akero Therapeutics (AKRO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Akero Therapeutics
Akero Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing transformational treatments for non-alcoholic steatohepatitis and other serious metabolic disorders. The company's product pipeline consists of AKR-001, for the treatment of non-alcoholic steatohepatitis, which are in clinical stage. Akero Therapeutics Inc. is based in San Francisco, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29-02-2024 | PM | AKRO | Akero Therapeutics | 1,521 | -0.99 | -0.82 | 0.00 | Akero Therapeutics GAAP EPS of -$0.99 misses by $0.12 [2/29/2024 7:30 AM] |
27.03 | -0.20 (-0.73%) |
27.93 | 0.70 (2.57%) |
11.25 - 58.38 | 1,489,519 | 1,080,000 | 6,789 | ||
| 11-08-2023 | PM | AKRO | Akero Therapeutics, Inc. | 2,150 | -0.60 | -0.62 | -0.77 | Akero Therapeutics GAAP EPS of -$0.60 [8/11/2023 6:29 AM] |
47.47 | 2.86 (6.41%) |
45.05 | 0.44 (0.99%) |
10.48 - 58.38 | 750,643 | 510,000 | 198 | ||
| 04-11-2022 | PM | AKRO | Akero Therapeutics | 1,575 | -0.92 | -0.73 | 0.00 | Akero Therapeutics GAAP EPS of -$0.92 misses by $0.20 [11/4/2022 7:29 AM] |
38.46 | -2.50 (-6.10%) |
40.53 | -0.43 (-1.05%) |
7.52 - 45.32 | 557,198 | 490,000 | 1,416 | ||
| 04-08-2022 | AH | 7:00 AM ET (Aug 4) |
AKRO | Akero Therapeutics | 387.00 | -0.77 | -0.85 | 0.00 | Akero Therapeutics GAAP EPS of -$0.77 beats by $0.10 [8/4/2022 5:37 PM] |
13.78 | 0.99 (7.74%) |
13.78 | 0.0 (0.00%) |
7.52 - 26.98 | 348,273 | 290,000 | 4,119 | |
| 06-05-2022 | PM | AKRO | Akero Therapeutics | 413.00 | -0.74 | -0.85 | 0.00 | Akero Therapeutics GAAP EPS of -$0.74 beats by $0.07 [5/6/2022 7:29 AM] |
11.16 | -0.17 (-1.50%) |
11.16 | 0.0 (0.00%) |
10.05 - 30.53 | 222,542 | 230,000 | 6,117 | ||
| 25-02-2022 | PM | AKRO | Akero Therapeutics | 593.00 | -0.93 | -0.81 | 0.00 | Akero Therapeutics GAAP EPS of -$0.93 misses by $0.13 [2/25/2022 7:42 AM] |
17.93 | -0.15 (-0.83%) |
18.08 | 0.0 (0.00%) |
15.70 - 34.87 | 50,428 | 170,000 | 56,290 | ||
| 12-11-2021 | PM | AKRO | Akero Therapeutics, Inc. | 898.39 | -0.70 | -0.91 | -0.63 | Akero Therapeutics EPS beats by $0.16 [11/12/2021 7:24 AM] |
25.37 | 0.57 (2.30%) |
24.80 | 0.0 (0.00%) |
17.66 - 34.87 | 45,946 | 150,000 | 3,381 | ||
|
||||||||||||||||||
| 13-08-2021 | PM | AKRO | Akero Therapeutics, Inc. | 667.00 | -0.83 | -0.72 | 0.00 | Akero Therapeutics EPS misses by $0.17 [8/13/2021 7:29 AM] |
18.95 | 0.30 (1.61%) |
18.65 | 0.0 (0.00%) |
17.66 - 37.94 | 232,322 | 270,000 | 4,895 | ||
| 16-03-2021 | PM | AKRO | Akero Therapeutics, Inc. | 1,160 | -0.86 | -0.58 | -0.55 | Akero Therapeutics EPS misses by $0.29 [3/16/2021 9:24 AM] |
31.80 | -1.13 (-3.43%) |
32.55 | -0.38 (-1.15%) |
12.51 - 41.16 | 275,614 | 250,720 | 741 | ||